Pharmacodynamics of meropenem in critically ill patients with febrile neutropenia and bacteraemia.
about
Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancerPharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patientsShort versus long infusion of meropenem in very-low-birth-weight neonatesClinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial.Pharmacokinetic/Pharmacodynamic Analysis of Meropenem for the Treatment of Nosocomial Pneumonia in Intracerebral Hemorrhage Patients by Monte Carlo Simulation.Carbapenem susceptibility breakpoints, clinical implications with the moving target.Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?Multicenter Study of the Relationship between Carbapenem MIC Values and Clinical Outcome of Patients with Acinetobacter Bacteremia.Population pharmacokinetics of the piperacillin component of piperacillin/tazobactam in pediatric oncology patients with fever and neutropenia.Effect of meropenem administration in extended infusion on the clinical outcome of febrile neutropenia: a retrospective observational study.Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients.Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
P2860
Q26825326-E74DAFAE-5EB7-417F-879C-45A3632E94FCQ35960828-663B4AE2-88BC-4E4A-AF12-A6DFAB4D275EQ36172523-9407AABD-4593-432C-8C19-46B9596FE8C2Q36633761-7868B3AB-B51E-4934-8651-FB65F321582AQ38693420-3B9C31FB-1C66-43D4-B32A-8F92D0F55362Q38751264-BE2EADBE-0A9E-4833-8F98-D63BA5D0B83FQ39344408-C970A417-FF6A-43C3-8B55-67694492BF4BQ39613942-3931A6D3-6EB4-45E3-BE02-C15F89F9FF7CQ40186288-EF6395CE-30CF-4BF0-8937-874C85787AD5Q40206253-E6616BE0-318B-47DF-BBB8-E896FED8346EQ40727311-1FED0AAE-C039-47AB-8100-A7D523E9F1B8Q58701649-6C8FFE42-D588-42FE-9ED5-C6657B53A174
P2860
Pharmacodynamics of meropenem in critically ill patients with febrile neutropenia and bacteraemia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Pharmacodynamics of meropenem ...... e neutropenia and bacteraemia.
@en
Pharmacodynamics of meropenem ...... e neutropenia and bacteraemia.
@nl
type
label
Pharmacodynamics of meropenem ...... e neutropenia and bacteraemia.
@en
Pharmacodynamics of meropenem ...... e neutropenia and bacteraemia.
@nl
prefLabel
Pharmacodynamics of meropenem ...... e neutropenia and bacteraemia.
@en
Pharmacodynamics of meropenem ...... e neutropenia and bacteraemia.
@nl
P2093
P1476
Pharmacodynamics of meropenem ...... e neutropenia and bacteraemia.
@en
P2093
Monchana Jullangkoon
Nanchanit Aeinlang
Natnicha Ingviya
Thanya Limapichat
Wibul Wongpoowarak
P304
P356
10.1016/J.IJANTIMICAG.2011.04.019
P577
2011-07-02T00:00:00Z